Browse by Uncontrolled Keywords

Export as [feed] Atom [feed] RSS
Group by: Year | Authors/Creators | Item Type | Full Text
Jump to: 2007 | 2005 | 2003 | 2002
Number of items: 4.

2007

Schmidt, MK; Reincke, S; Broeks, A; Braaf, LM; Hogervorst, FBL; Tollenaar, R; Johnson, N; Fletcher, O; Peto, J; Tommiska, J; +8 more... Blomqvist, C; Nevanlinna, HA; Healey, CS; Dunning, AM; Pharoah, PDP; Easton, DF; Doork, T; Van't Veer, LJ; (2007) Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. Cancer research, 67 (19). pp. 9584-9590. ISSN 0008-5472 DOI: https://doi.org/10.1158/0008-5472.CAN-07-0738 Full text not available from this repository.

2005

Turner, PC; Sylla, A; Kuang, SY; Marchant, CL; Diallo, MS; Hall, AJ; Groopman, JD; Wild, CP; (2005) Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure. Cancer epidemiology, biomarkers & prevention, 14 (8). pp. 2053-2055. ISSN 1055-9965 DOI: https://doi.org/10.1158/1055-9965.EPI-04-0923 Full text not available from this repository.

2003

Adami, HO; Kuper, H; Andersson, SO; Bergstrom, R; Dillner, J; (2003) Prostate cancer risk and serologic evidence of human papilloma virus infection: A population-based case-control study. Cancer epidemiology, biomarkers & prevention, 12 (9). pp. 872-5. ISSN 1055-9965 http://researchonline.lshtm.ac.uk/id/eprint/16013 Full text not available from this repository.

2002

Meijers-Heijboer, H; van Den Ouweland, A; Klijn, J; Wasielewski, M; de Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; van Veghel-Plandsoen, M; +31 more... Elstrodt, F; van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, DF; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, DG; Houlston, R; Murday, V; Narod, S; Peretz, T; Peto, J; Phelan, C; Zhang, HX; Szabo, C; Devilee, P; Goldgar, D; Futreal, PA; Nathanson, KL; Weber, BL; Rahman, N; Stratton, MR; (2002) Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature genetics, 31 (1). pp. 55-59. ISSN 1061-4036 DOI: https://doi.org/10.1038/ng879 Full text not available from this repository.

This list was generated on Mon Mar 18 23:02:09 2019 GMT.